Lactate's Role in Flap Ischemia and Fibrosis
Author Information
Author(s): Xu Yining, Ma Xianhui, Ni Weiyu, Zheng Lin, Lin Zhongnan, Lai Yingying, Yang Ningning, Dai Zhanqiu, Yao Teng, Chen Zeyang, Shen Lifeng, Wang Haitao, Wang Long, Wu Yizheng, Gao Weiyang
Primary Institution: Wenzhou Medical University
Hypothesis
Does lactate overproduction contribute to flap necrosis and its underlying mechanisms?
Conclusion
The study suggests that PKM2-derived lactate exacerbates flap fibrosis and ischemia by promoting endothelial-to-mesenchymal transition through Twist1 lactylation.
Supporting Evidence
- Endothelial-specific deletion of PKM2 reduces flap necrosis and fibrosis.
- Serum lactate levels in patients correlate with flap ischemia severity.
- Lactate promotes endothelial dysfunction and mesenchymal transition.
- Twist1 lactylation is enhanced by lactate, leading to increased TGF-β signaling.
- Knockdown of PKM2 reduces lactate accumulation and improves flap outcomes.
Takeaway
Lactate, a substance produced when the body doesn't get enough oxygen, can make skin flaps heal poorly after surgery. This study shows that too much lactate can cause problems in healing.
Methodology
The study involved RNA sequencing, in vivo and in vitro experiments, and various assays to assess lactate levels, endothelial function, and fibrosis.
Potential Biases
Potential bias in patient selection and retrospective analysis.
Limitations
The study primarily focuses on mouse models and may not fully translate to human conditions.
Participant Demographics
48 patients who underwent flap transplantation, categorized by ischemia severity.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website